Tag: kestrel biologics
-
Kestrel Biologics Hits Its Hiring Target, With Help It Didn’t Expect to Need
Kestrel Biologics says it has nearly doubled its Bellwater workforce, hitting its two-year hiring target partly by absorbing technicians laid off by rival Ridgeline Therapeutics.
-
Kestrel Biologics Weighs West Bellwater for New Manufacturing Site
Kestrel Biologics is scouting sites for a second manufacturing facility, including in West Bellwater, as the Foundry Row biotech firm outgrows its current lab and production space.
-
Gene-Therapy Trial Clears Early Safety Hurdle for Kestrel Biologics
Kestrel Biologics says its lead gene-therapy candidate has cleared an early safety milestone in its Phase 1 trial, a result executives call validation for the Foundry Row biotech firm’s $64 million funding round.
-
Foundry Row Is Running Out of Lab Space, and Biotech Firms Are Feeling It
Wet-lab vacancy in Foundry Row has fallen below 4 percent, a shortage that biotech executives say is already complicating expansion plans and pushing some companies to consider sites outside Bellwater.
-
Lab Technicians at Kestrel Biologics Explore Union Organizing
A group of Kestrel Biologics lab technicians has quietly begun organizing around scheduling and safety-staffing concerns, a potential first test of union interest in Bellwater’s fast-growing biotech sector.